BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Other Current Liabilities

Track Fidelity Select Biotechnology Portfolio's other current liabilities ($32M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$32.15M

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Other Current Liabilities History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Other Current Liabilities Comparison

Loading

Fidelity Select Biotechnology Portfolio Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

Fidelity Select Biotechnology Portfolio's other current liabilities stands at $32M as of October 2023. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Fidelity Select Biotechnology Portfolio's other current liabilities is expanding or contracting. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Fidelity Select Biotechnology Portfolio's other current liabilities evolved across reporting periods, while the comparison chart places FBIOX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.